Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid–Involved Overdose Deaths — 27 States, 2013–2014
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In March and October 2015, the Drug Enforcement Administration (DEA) and CDC, respectively, issued nationwide alerts identifying illicitly manufactured fentanyl (IMF) as a threat to public health and safety (1,2). IMF is unlawfully produced fentanyl, obtained through illicit drug markets, includes fentanyl analogs, and is commonly mixed with or sold as heroin (1,3,4). Starting in 2013, the production and distribution of IMF increased to unprecedented levels, fueled by increases in the global supply, processing, and distribution of fentanyl and fentanyl-precursor chemicals by criminal organizations (3). Fentanyl is a synthetic opioid 50-100 times more potent than morphine (2).* Multiple states have reported increases in fentanyl-involved overdose (poisoning) deaths (fentanyl deaths) (2). This report examined the number of drug products obtained by law enforcement that tested positive for fentanyl (fentanyl submissions) and synthetic opioid-involved deaths other than methadone (synthetic opioid deaths), which include fentanyl deaths and deaths involving other synthetic opioids (e.g., tramadol). Fentanyl deaths are not reported separately in national data. Analyses also were conducted on data from 27 states(†) with consistent death certificate reporting of the drugs involved in overdoses. Nationally, the number of fentanyl submissions and synthetic opioid deaths increased by 426% and 79%, respectively, during 2013-2014; among the 27 analyzed states, fentanyl submission increases were strongly correlated with increases in synthetic opioid deaths. Changes in fentanyl submissions and synthetic opioid deaths were not correlated with changes in fentanyl prescribing rates, and increases in fentanyl submissions and synthetic opioid deaths were primarily concentrated in eight states (high-burden states). Reports from six of the eight high-burden states indicated that fentanyl-involved overdose deaths were primarily driving increases in synthetic opioid deaths. Increases in synthetic opioid deaths among high-burden states disproportionately involved persons aged 15-44 years and males, a pattern consistent with previously documented IMF-involved deaths (5). These findings, combined with the approximate doubling in fentanyl submissions during 2014-2015 (from 5,343 to 13,882) (6), underscore the urgent need for a collaborative public health and law enforcement response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of the use of fentanyl analgesia in the management of acute pain in adults.
Peng, P. W. H., & Sandler, A. N. (1999) · Anesthesiology · doi:10.1097/00000542-199902000-00034 · Cited by 408
Drug-poisoning deaths involving heroin: United States, 2000-2013.
Hedegaard, H. B., Chen, L.-H., & Warner, M. (2015) · PubMed · Cited by 202
Increases in Fentanyl-Related Overdose Deaths — Florida and Ohio, 2013–2015
Peterson, A. B., Gladden, R. M., Delcher, C., Spies, E., Garcia-Williams, A., Wang, Y., Halpin, J., Zibbell, J., McCarty, C. L., DeFiore-Hyrmer, J., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6533a3 · Cited by 188
Self-citation
Cited by
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Self-citationDrug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731
Self-citationThe rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis
Ciccarone, D. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000717 · Cited by 987
Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016.
Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a1 · Cited by 821
Self-citationGlobal patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016
Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018) · Science · doi:10.1126/science.aau1184 · Cited by 667
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Fentanyl in the US heroin supply: A rapidly changing risk environment
Ciccarone, D. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.010 · Cited by 450
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Quantifying the Epidemic of Prescription Opioid Overdose Deaths
Seth, P., Rudd, R. A., Noonan, R. K., & Haegerich, T. M. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304265 · Cited by 425
Self-citationKariisa, M., Scholl, L., Wilson, N., Seth, P., & Hoots, B. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6817a3 · Cited by 400
Self-citationO’Donnell, J. K., Gladden, R. M., & Seth, P. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6634a2 · Cited by 311
Self-citationOpioid-related mortality in rural America: Geographic heterogeneity and intervention strategies
Rigg, K. K., Monnat, S. M., & Chavez, M. N. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.011 · Cited by 294
Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020) · American Journal of Public Health · doi:10.2105/ajph.2019.305412 · Cited by 285
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’
Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.06.004 · Cited by 277
The Opioid Crisis: a Comprehensive Overview
Vadivelu, N., Kai, A. M., Kodumudi, V., Sramcik, J., & Kaye, A. D. (2018) · Current Pain and Headache Reports · doi:10.1007/s11916-018-0670-z · Cited by 258
Addressing the Fentanyl Threat to Public Health
Frank, R. G., & Pollack, H. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1615145 · Cited by 242
Illicit fentanyls in the opioid street market: desired or imposed?
Mars, S. G., Rosenblum, D., & Ciccarone, D. (2019) · Addiction · doi:10.1111/add.14474 · Cited by 185
“Overall, market conditions appear to point to supply shocks and heroin shortages before the introduction of fentanyl to the opioid supply, both in the United States and parts of Europe, with the United States experiencing rising demand and increasing prices.”
InfluentialFentanyl shock: The changing geography of overdose in the United States
Zoorob, M. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.04.010 · Cited by 160
Morgan, J. R., Schackman, B. R., Weinstein, Z. M., Walley, A. Y., & Linas, B. P. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.02.031 · Cited by 159
“Finally, while we were not able to identify the substances linked to each overdose event, the higher overdose risk in the Northeast and Midwest compared to the South may be partially attributable to the greater penetration of fentanyl in specific illicit opioid markets (Gladden et al., 2016).”
BackgroundPalamar, J. J., Ciccarone, D., Rutherford, C., Keyes, K. M., Carr, T. H., & Cottler, L. B. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109398 · Cited by 147
Park, J. N., Rashidi, E., Foti, K., Zoorob, M., Sherman, S., & Alexander, G. C. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108416 · Cited by 128
“According to the CDC, levels of fentanyl seizures have been shown to be correlated with synthetic opioid deaths, demonstrating the predictive potential of this underutilized data source (Gladden et al., 2016).”
BackgroundIrvine, M. A., Oller, D., Boggis, J., Bishop, B., Coombs, D., Wheeler, E., Doe-Simkins, M., Walley, A. Y., Marshall, B. D. L., Bratberg, J., et al. (2022) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00304-2 · Cited by 127
Bardwell, G., Fleming, T., Collins, A. B., Boyd, J., & McNeil, R. (2019) · Journal of Urban Health · doi:10.1007/s11524-018-0294-y · Cited by 93
Baumann, M. H., Majumdar, S., Le Rouzic, V., Hunkele, A., Uprety, R., Huang, X. P., Xu, J., Roth, B. L., Pan, Y.-X., & Pasternak, G. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.016 · Cited by 92
“Discussion The US is currently experiencing an epidemic of opioid-related overdose deaths, and this phenomenon is exacerbated by the increasing availability of illicitly manufactured fentanyl in the recreational drug marketplace (Frank and Pollack, 2017; Gladden et al., 2016; Rudd et al., 2016).”
BackgroundInfluentialMedications for opioid use disorder: bridging the gap in care.
Volkow, N. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32893-3 · Cited by 79
McGowan, C. R., Harris, M., Platt, L., Hope, V., & Rhodes, T. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.04.017 · Cited by 71
Zibbell, J. E., Aldridge, A. P., Cauchon, D., DeFiore-Hyrmer, J., & Conway, K. P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.14666 · Cited by 69
Morgan, J. R., Walley, A. Y., Murphy, S. M., Chatterjee, A., Hadland, S. E., Barocas, J., Linas, B. P., & Assoumou, S. A. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108764 · Cited by 67
“I probably got a minute”: Perceptions of fentanyl test strip use among people who use stimulants
Reed, M. K., Roth, A. M., Tabb, L. P., Groves, A. K., & Lankenau, S. E. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103147 · Cited by 65
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00046 · Cited by 55
Testing the test strips: laboratory performance of fentanyl test strips
Halifax, J. C., Lim, L., Ciccarone, D., & Lynch, K. L. (2024) · Harm Reduction Journal · doi:10.1186/s12954-023-00921-8 · Cited by 45
“Beginning in 2014, deaths attributed to IMF have risen alongside seizures [4–6].”
BackgroundCook, J. L. (2022) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2022.07.003 · Cited by 42
Chronic Primary Pain of the Spine: an Integrative Perspective Part 2
Williamson, T. J., Bolles, C. L., Hedges, N. A., & Kettner, N. W. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00779-6 · Cited by 11
Drug supply measures and drug overdose mortality in the era of fentanyl and stimulants
Cano, M., Timmons, P., Hooten, M., & Sweeney, K. (2023) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2023.100197 · Cited by 17
“…the positive association between seized fentanyl/fentanyl-related compound reports and drug overdose deaths in individual states and the US overall (Gladden et al., 2016; Rosenblum et al., 2020; Slavova et al., 2017; Zibbell et al., 2019, 2023; Zoorob, 2019), and results of the present study add…”
BackgroundResultInfluentialDeath associated with brorphine, an emerging novel synthetic opioid
Vohra, V., King, A. M., Jacobs, E., & Aaron, C. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1879111 · Cited by 16
Phelps, C., Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70084 · Cited by 6
Metadata
- Authors
- Gladden, R. M., Martinez, P., & Seth, P.
- Venue
- MMWR. Morbidity and Mortality Weekly Report
- Published
- 2016-08-26
- Volume
- 65
- Issue
- 33
- Pages
- 837-843
- ISSN
- 0149-2195 (ISSN-L)
- 1545-861X
- OpenAlex
- W2514932497
- Cited by
- 426
- References
- 3
- FWCI
- 54.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.